The Health Insurance Review and Assessment Service says five medicines were added to a list of ‘items not to be withdrawn from market’ totaling 567 items in October, while 4 items were delisted.
Those newly added involved were Choong-wae Pharm’s Pamu tablet/injection, Yungjin’s Placong tablet/injection, and Asia Pharm’s digoxin injection
The prices of ‘items not to be withdrawn from mark...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.